Independence Health Group continues to focus on opportunities to expand our coverage to more consumers, families, businesses and other organizations even as we navigate a complex and evolving healthcare environment, said Gregory Deavens, Independence Health Group president and CEO, in a news release
Acta Pharm Sin B 12(11):40404055
Erythrocyte glutathione transferase: a potential new biomarker in chronic kidney diseases which correlates with plasma homocysteine
Emotional wellbeing The emotional effects of gout can have just as much impact as the physical symptoms
Although the use of a single MSC line, while providing important proof-of-concept data, requires future validation across multiple donor-derived lines to assess reproducibility
The science is the same as our Combo pack: dual-pathway GH stimulation producing synergistic release